RxDoctor Payments Data

Doyle Miller, MD

Orthopaedic Surgery · Richland, WANPI 1447423934

Payments from drug & device makers

$8,456in general payments, 2019–2025

Across 43 payments — averaging $196.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$7K
  • Summit Surgical Corp.$782
  • Stryker$481
  • Zimmer Biomet$149
  • Invictus Surgical Incorporated$135
  • Heron Therapeutics, Inc.$119
  • plus $132 from 4 others

What the payments were for

  • Travel & lodging$1,30515%
  • Food & beverage$2,14025%
  • Education$5,01159%

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex24$6,658
Summit Surgical Corp.1$782
Stryker9$481
Zimmer Biomet1$149
Invictus Surgical Incorporated1$135
Heron Therapeutics, Inc.2$119
Onkos Surgical, Inc.1$55
Vericel Corporation2$43
Johnson & Johnson1$18
Si-bone, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,456 in reported general payments places this provider in the 70th percentile of 495 orthopaedic surgery providers in Washington.

See all orthopaedic surgery providers in Washington

Medicare billing

Part B allowed, 2024
$112,785
Medicare patients
203
Services billed
1,819

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam15$33

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Richland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →